Literature DB >> 25225370

Mathematical model of renal interstitial fibrosis.

Wenrui Hao1, Brad H Rovin2, Avner Friedman3.   

Abstract

Lupus nephritis (LN) is an autoimmune disease that occurs when autoantibodies complex with self-antigen and form immune complexes that accumulate in the glomeruli. These immune complexes initiate an inflammatory response resulting in glomerular injury. LN often concomitantly affects the tubulointerstitial compartment of the kidney, leading first to interstitial inflammation and subsequently to interstitial fibrosis and atrophy of the renal tubules if not appropriately treated. Presently the only way to assess interstitial inflammation and fibrosis is through kidney biopsy, which is invasive and cannot be repeated frequently. Hence, monitoring of disease progression and response to therapy is suboptimal. In this paper we describe a mathematical model of the progress from tubulointerstitial inflammation to fibrosis. We demonstrate how the model can be used to monitor treatments for interstitial fibrosis in LN with drugs currently being developed or used for nonrenal fibrosis.

Entities:  

Keywords:  math modeling; renal fibrosis; tubulointerstitial inflammation

Mesh:

Substances:

Year:  2014        PMID: 25225370      PMCID: PMC4191765          DOI: 10.1073/pnas.1413970111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Monocyte chemoattractant protein-1: does it play a role in diabetic nephropathy?

Authors:  Takashi Wada; Hitoshi Yokoyama; Kouji Matsushima; Ken-ichi Kobayashi
Journal:  Nephrol Dial Transplant       Date:  2003-03       Impact factor: 5.992

Review 2.  Treatment targets in renal fibrosis.

Authors:  Peter Boor; Katarína Sebeková; Tammo Ostendorf; Jürgen Floege
Journal:  Nephrol Dial Transplant       Date:  2007-09-21       Impact factor: 5.992

3.  The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients.

Authors:  A S Alvarado; A Malvar; B Lococo; V Alberton; F Toniolo; H N Nagaraja; B H Rovin
Journal:  Lupus       Date:  2014-01-08       Impact factor: 2.911

Review 4.  Macrophages and renal fibrosis.

Authors:  Madeleine A Vernon; Katie J Mylonas; Jeremy Hughes
Journal:  Semin Nephrol       Date:  2010-05       Impact factor: 5.299

Review 5.  Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases.

Authors:  Hong Zhao; Yanting Dong; Xinrui Tian; Thian Kui Tan; Zhuola Liu; Ye Zhao; Yun Zhang; David Ch Harris; Guoping Zheng
Journal:  World J Nephrol       Date:  2013-08-06

6.  Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop.

Authors:  Michael S Simonson; Faramarz Ismail-Beigi
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

7.  Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Authors:  Brad H Rovin; Huijuan Song; Dan J Birmingham; Lee A Hebert; Chack Yung Yu; Haikady N Nagaraja
Journal:  J Am Soc Nephrol       Date:  2004-12-15       Impact factor: 10.121

8.  Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney.

Authors:  J Floege; K L Hudkins; F Eitner; Y Cui; R S Morrison; M A Schelling; C E Alpers
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

9.  Proteinuria and tubulointerstitial lesions in lupus nephritis.

Authors:  G S Hill; M Delahousse; D Nochy; C Mandet; J Bariéty
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

10.  Histopathologic features aid in predicting risk for progression of IgA nephropathy.

Authors:  Michael Walsh; Aylin Sar; Diane Lee; Serdar Yilmaz; Hallgrimur Benediktsson; Braden Manns; Brenda Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

View more
  14 in total

1.  Fibroblasts: Diverse Cells Critical to Biomaterials Integration.

Authors:  Riley T Hannan; Shayn M Peirce; Thomas H Barker
Journal:  ACS Biomater Sci Eng       Date:  2017-06-13

Review 2.  Computational modeling of cardiac fibroblasts and fibrosis.

Authors:  Angela C Zeigler; William J Richardson; Jeffrey W Holmes; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2015-12-01       Impact factor: 5.000

3.  Tubulointerstitial Fibrosis of Living Donor Kidneys Associates with Urinary Monocyte Chemoattractant Protein 1.

Authors:  Xiangling Wang; John C Lieske; Mariam P Alexander; Muthuvel Jayachandran; Aleksandar Denic; Jerry Mathew; Lilach O Lerman; Walter K Kremers; Joseph J Larson; Andrew D Rule
Journal:  Am J Nephrol       Date:  2016-06-10       Impact factor: 3.754

4.  [Vitamin D receptor and monocyte chemoattractant protein-1 expressions in peripheral blood mononuclear cells in patients with systemic lupus erythemaotsus].

Authors:  Yuxi Huang; Hao Zhang; Shuang Zhang; Jian Sun
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

5.  Modeling Granulomas in Response to Infection in the Lung.

Authors:  Wenrui Hao; Larry S Schlesinger; Avner Friedman
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

6.  Mathematical model on Alzheimer's disease.

Authors:  Wenrui Hao; Avner Friedman
Journal:  BMC Syst Biol       Date:  2016-11-18

7.  A Mathematical Model of Idiopathic Pulmonary Fibrosis.

Authors:  Wenrui Hao; Clay Marsh; Avner Friedman
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

8.  Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.

Authors:  Wenrui Hao; Avner Friedman
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

9.  Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model.

Authors:  Xiulan Lai; Avner Friedman
Journal:  BMC Syst Biol       Date:  2017-07-19

10.  Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis: A Large Multicenter Cross-Sectional Study.

Authors:  Yun Pang; Ying Tan; Yongzhe Li; Jianchun Zhang; Yongbing Guo; Zhiling Guo; Chengying Zhang; Feng Yu; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.